一般演題（ポスター）50 EGFR陽性肺癌4

[P50-5] EGFR ex19del and ex21L858R NSCLC cells adapt different signaling network to EGFR-TKI and ramucirumab

^○Zhao Hai Lu¹, Tomoko Matsui², Xueqian Gong¹, Audrey Au¹, Krithi Bala¹, Amelie Forest¹, Deli Liu¹, Andrew Capen¹, Hua-chen Chang¹, Jack Dempsey¹, Veena Coothan Kandaswamy¹, Helen Won¹, Sotaro Enatsu², Anke Klippel¹ (1.Eli Lilly and company, Indianapolis, 2.Eli Lilly Japan k.k., Kobe, Japan)

アンコール演題